Our Technologies

Read about our available technologies and get in touch with our team

Filter

Sectors

Industries

Clear all filters

Red blood cell-derived vesicles (RBCVs) for use in targeted delivery of thrombolytic drugs to blood clots.
Small molecule inhibitors with potential for use in the treatment of neurodegenerative diseases such as Huntington's disease, viral conditions such as HIV, and cancers
BWSQ is the leading tool for assessing benzodiazepine withdrawal symptoms, used in a number of clinical trials involving benzodiazepines.
A fully flexible, scalable and low-cost detection platform to sense multiple protein targets simultaneously by grafting specific sequences along the backbone of a double-stranded DNA carrier.
A novel system that measures voltage in tissue and differentiates cancerous from non-cancerous tissue.
Smart phone Ballistocardiography (BCG) is a novel measurement method that requires fewer sensors (≥ 1) placed above the heart. It measures the physical movement of the chest due to the heart beating rather than electrical signals measured by ECG
ENGINI is a next generation neural implant technology for brain machine interfaces (BMIs) applicable to both central and peripheral nervous system
Professor Molly Steven's Osteochondral Scaffold is a 3D fibrous scaffold that structurally mimics articular cartilage
SPARTA™: a comprehensive nanoparticle analysis platform based on Raman spectroscopy providing simultaneous size, composition, and functionalisation analysis
A novel and patented production method introducing carbon nanotubes (CNTs) to carbon fibre (CF) composites to give enhanced electrical, mechanical and electrical properties.

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Licensing and IP performance 2019/20

Inventions disclosed

Imperial inventors submitted 250 invention disclosures to our IPC team during the year

Active licences

Imperial College London's licensing portfolio comprises 244 licences

Patents filed

Imperial filed 137 patents (including PCT applications) during the year

Patent portfolio

Imperial's patent portfolio reached 331 patents during the year

Upcoming Events

Imperial.tech.pitch events – learn more and sign up

Imperial.tech.pitch events – learn more and sign up

Event date - October 1, 2023

Learn about our programme of events and sign up to be alerted for future events Find out more

Latest News

Accelerated development of a potential treatment for cystic fibrosis

Accelerated development of a potential treatment for cystic fibrosis

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more

Natural Killer – licensing a cell therapy

Natural Killer – licensing a cell therapy

Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more

Loading...